Delaware — drug testing employment law

At a glance: Delaware

Overview: drug testing in Delaware

Delaware legalized adult-use cannabis in 2023 (Delaware Marijuana Control Act, HB 1/HB 2) and had previously enacted a comprehensive medical cannabis program in 2011. Workplace testing remains broadly permissible, but the Delaware Medical Marijuana Act (16 Del. C. § 4905A) contains an express anti-discrimination provision for qualifying patients, preserving employer rights over impairment and federal-contract roles.

Cannabis law and workplace testing

The Medical Marijuana Act prohibits discrimination against registered qualifying patients on the basis of patient status or a positive cannabis test, unless the employer would lose a federal monetary benefit or fail to comply with federal law, or the employee was impaired during work hours. The adult-use law does not contain an equivalent employment anti-discrimination provision; recreational users have less protection than registered patients.

Specific testing rules in Delaware

The table below summarizes how Delaware typically treats four common workplace testing scenarios. Each row reflects the dominant statutory or case-law position; carve-outs (federal-contractor, DOT-regulated, safety-sensitive, etc.) may shift any individual analysis.

Federal overlay: DOT and federal contractors

In all U.S. states — including Delaware — DOT-regulated employees (safety-sensitive roles in transportation industries under 49 CFR Part 40) and federal-contractor employees subject to the federal Drug-Free Workplace Act of 1988 are testable under federal rules regardless of state cannabis status or workplace-testing restrictions. State law cannot reduce federal testing obligations for these populations. Where state law otherwise restricts cannabis testing, the federal-overlay carve-out typically preserves the employer's authority for these federally affected roles.

For employers in Delaware

Delaware employers can test broadly, but cardholder status under the Medical Marijuana Act is protected: document on-duty impairment or federal-contract exposure before taking action against a registered patient who tests positive. The adult-use law does not create equivalent employment protection.

• Written policy. Document the substances tested, the cutoff levels, the testing modalities (urine / oral fluid / hair), and the consequences of a non-negative result.
• Notice. Provide written notice before testing begins and obtain signed acknowledgement where the state requires it.
• Certified laboratory. Use a SAMHSA-certified or equivalent laboratory; document chain of custody.
• Confirmation testing. Confirm any non-negative initial result with mass-spectrometry (GC-MS or LC-MS/MS) before any adverse action.
• MRO review. Engage a qualified Medical Review Officer to review all non-negative results before reporting to the employer.
• Safety-sensitive designations. If the role is statutorily exempt as safety-sensitive, document the designation in writing using the state\'s statutory definition.
• Medical cannabis disclosures. Where state law provides patient protection, engage an interactive accommodation process before adverse action.

For workers in Delaware

Delaware medical cannabis cardholders have statutory anti-discrimination protection. Recreational use is now legal, but recreational use does not currently carry the same employment protection — recreational users may face adverse action for a positive test.

• Know the policy. Request a copy of your employer\'s written testing policy — it should specify when testing occurs, what is tested, and how to challenge a result.
• Disclose medications to the MRO, not the employer. The Medical Review Officer reviews non-negative results before they are reported and can resolve a legitimate prescription explanation.
• Document medical cannabis status. If you are a registered medical cannabis patient in a state with patient protection, document your status with HR before testing.
• Confirmation testing. Any non-negative initial result should be confirmed by GC-MS or LC-MS/MS before adverse action.
• Appeal rights. Many state statutes provide an appeals process — read your employer\'s policy carefully.

Key statutes and citations

The following statutory citations are the primary controlling authority for drug testing employment law in Delaware. We provide citations only — confirm current text via your state legislature\'s codified statutes (or an authoritative legal research platform) before relying on this information.

• Delaware Medical Marijuana Act — 16 Del. C. § 4901A et seq.
• Delaware Marijuana Control Act — HB 1 / HB 2 (2023)

Multi-state employers operating in Delaware

A national or multi-state employer\'s policy that works in a permissive state (e.g., Alabama or Texas) may not be lawful as applied to employees in Delaware, and vice versa. Common multi-state pitfalls include: applying a national pre-employment cannabis screen in jurisdictions that prohibit it; treating a positive cannabis test as automatic disqualification where state law restricts that outcome; failing to designate safety-sensitive roles in compliance with the relevant state\'s statutory definition; and not maintaining state-specific written policies and acknowledgements. For multi-state programs, see our multi-state employer guide.

How this page is built and reviewed

This page combines a structured data layer (cannabis status, statutory protection levels, voluntary program details, statute citations) with state-specific narrative drafted from primary statutes and authoritative secondary sources. Every claim should trace either to a statute citation, an authoritative secondary source (e.g., NCSL, EEOC, DOT, SHRM, ASAM), or general background knowledge clearly framed as such. The page is reviewed against the listed sources on each material amendment.

Found something out of date? Let us know — we update state pages as statutes and case law evolve.